New cancer clinical trial: SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Published on: February 28, 2018 at 12:00PM
Conditions:   Colorectal Cancer Stage III;   Adjuvant Chemotherapy
Interventions:   Drug: Oxaliplatin;   Drug: Tegafur，gimeracil and oteracil potassium;   Drug: Xeloda
Sponsors:   Beijing Cancer Hospital;   Peking Union Medical College Hospital;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Peking University People's Hospital
Recruiting
http://ift.tt/2GXmxHH